SONM Earnings

Quarterly EPS
$-9.32
Q3 2024
$-41.04
Q4 2024
$1.41
Q1 2025
$-14.15
Q2 2025
$-4.83
Q3 2025
$0.00
Q4 2025
$5.01
Q1 2026
$-0.92
Q2 2026
Latest RevenueN/A
Latest Net Income-1247000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.920-1247000+93.5%
Q1 2026$5.0106.3M+255.3%
Q4 2025
Q3 2025-$4.8316.2M-4753000+7.9%+48.2%
Q2 2025-$14.150-7475000-100.0%+44.2%
Q1 2025$1.410458.0K-100.0%+112.1%
Q4 2024-$41.0415.0M-21614000+11.6%-1,873.1%
Q3 2024-$9.3215.0M-2512000-45.5%-531.5%
Q2 2024-$25.3811.5M-6616000
Q1 2024-$11.7016.8M-2906000
Q4 2023-$2.0813.4M-1353000
Q3 2023$2.1627.6M527.0K
DNA X (SONM) — Earnings